| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe7e0952f10716932f0edd46bec49f52 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf5211977213d756054da14ab445621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601eeca06cd7718cb17cf59d5b0d53ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1832d561de4a08d0fa4a3bf53501579b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afbde4deea33a9d94f1672d0ad318e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50be31f767421663ce24f49cba63e85c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40fc24794c27c7f32f7d38ab88e3919
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951c1dc68d4def81f8864ad78b99029c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c03c4b181e8ddc6eed496dcf3de10c8 |
| publicationDate |
2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013108869-A1 |
| titleOfInvention |
Therapeutic or prophylactic agent for cancer |
| abstract |
Disclosed are: a novel means useful for the treatment and prevention of cancer; and a novel therapeutic/prophylactic means effective even for cancer that is resistant to anti-cancer agents. As a result of extensive studies, the inventors of the present application have identified ErbB2 as a cell membrane receptor for CCN2. A first therapeutic or prophylactic agent for cancer according to the present invention comprises a substance capable of inhibiting the interaction between CCN2 and ErbB2 (i.e., a CCN2-ErbB2 interaction inhibitor) as an active ingredient. A second therapeutic or prophylactic agent for cancer according to the present invention comprises a CCN2-ErbB2 interaction inhibitor as an active ingredient and is used in combination with an anti-cancer agent capable of inducing apoptosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3741389-A1 |
| priorityDate |
2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |